Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
STRONG BUY! Kurs eskaliert - A Star is Born!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3C5RW | ISIN: SE0016609846 | Ticker-Symbol: 87I
Frankfurt
21.01.25
10:31 Uhr
1,504 Euro
+0,170
+12,74 %
1-Jahres-Chart
FLAT CAPITAL AB Chart 1 Jahr
5-Tage-Chart
FLAT CAPITAL AB 5-Tage-Chart
RealtimeGeldBriefZeit
1,4521,50221.01.
GlobeNewswire (Europe)
105 Leser
Artikel bewerten:
(0)

Flat Capital AB: Flat invests 49 MSEK in a 'mini-portfolio' consisting of four US-based AI companies

Finanznachrichten News

Flat Capital AB (publ) ("Flat") invests approx. 49 MSEK in a 'mini-portfolio' consisting of four prominent US-based AI companies. The opportunity was sourced from a leading actor within the AI sector, through Flat's network, and the investment is made through a so-called Special Purpose Vehicle ("SPV"), which entails market-based management costs.

The first holding, which accounts for approx. 34.3 MSEK (70%) of the invested amount, has not yet announced its operations but is a so-called 'seed investment' that intends to develop and launch a new AI hardware product. We intend to provide further information on the holding when it is publicly announced.

The second holding, Anysphere, which accounts for approx. 6.9 MSEK (14%) of the invested amount, is the creator behind the product Cursor which is an AI-powered code editor that uses advanced AI models to help developers write, improve and generate code in a faster and smarter way.

The third holding, Speak, which accounts for approx. 4.4 MSEK (9%) of the invested amount, is an AI-powered language learning platform that focuses on improving the user's fluency in spoken languages through personalized lessons and AI technology.

The fourth holding, Chai Discovery, which accounts for approx. 3.3 MSEK (7%) of the invested amount, develops AI models to predict the structures and interactions of biomolecules such as proteins, DNA and RNA, with the aim of accelerating drug development and biological research.



Flat's investment is made through a so-called SPV, a structure that entails certain recurring administrative costs as well as a profit sharing mechanism upon realization of any profit. The costs of the SPV structure are considered to be in line with market conditions and will not materially affect Flat's overall costs. Annual running costs are estimated to be less than 0.1% of the net asset value at the time of investment.

Hanna Andreen, CEO:
"It's fantastic that we (Flat's shareholders) get the chance to invest in an AI portfolio consisting of some of the most prominent and promising companies led by experts in the field of AI! We look forward to following their respective journeys going forward!"

For more information and news about;

  • Anysphere / Cursor, visit: https://www.cursor.com/blog
  • Speak, visit: https://www.speak.com/blog
  • Chai, visit: https://www.chaidiscovery.com/

For further information, please contact:
Hanna Andreen, CEO, hw@flatcapital.com, +46 (0) 70 661 60 05

Certified Adviser:
Augment Partners AB, info@augment.se, +46 (0) 8 604 22 55

About Flat Capital:
Flat Capital is an investment company that focuses on growth stage companies with prominent entrepreneurs in leading positions and primarily makes investments through its network of world-class investors and entrepreneurs. The company was founded in 2013 by entrepreneurs Nina and Sebastian Siemiatkowski (founders and CEOs of Milkywire and Klarna, respectively) and is led by CEO Hanna Andreen together with an experienced board of directors. Examples of portfolio companies include OpenAI, Klarna, Perplexity, SpaceX and Figma. The company aims to provide long-term capital and is essentially a passive minority shareholder, while Flat Capital's experience and network are available to the extent the entrepreneur wishes. The aim is to facilitate successful company building and enable exposure to otherwise hard-to-reach and promising companies. More information is available at www.flatcapital.com

Note: This is a non-official translation of the Swedish original text. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail.

© 2025 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.